| Literature DB >> 35426538 |
Paulo Bastos1, Bruna Meira2, Marcelo Mendonça3,4, Raquel Barbosa5,6.
Abstract
Parkinson's disease (PD) is the fastest growing neurodegenerative disease, but disease-modifying or preventive treatments are lacking. Physical activity is a modifiable factor that decreases the PD risk and improves motor symptoms in PD. Understanding which dimensions of gait performance correlate with physical activity in PD can have important pathophysiological and therapeutic implications. Clinical/demographic data together with physical activity levels were collected from thirty-nine PD patients. Gait analysis was performed wearing seven inertial measurement units on the lower body, reconstructing the subjects' lower body motion using 3D kinematic biomechanical models. Higher physical activity scores were significantly correlated with MDS-UPDRS part III scores (r = - 0.58, p value = 9.2 × 10-5), age (r = - 0.39, p value = 1.5 × 10-2) and quality-of-life (r = - 0.47, p value = 5.9 × 10-3). Physical activity was negatively associated with MDS-UPDRS part III scores after adjusting for age and disease duration (β = - 0.08530, p value = 0.0010). The effect of physical activity on quality-of-life was mediated by the MDS-UPDRS part III (62.10%, 95% CI = 0.0758-1.78, p value = 0.022). The level of physical activity was correlated primarily with spatiotemporal performance. While spatiotemporal performance displays the strongest association with physical activity, other quality-of-movement dimensions of clinical relevance (e.g., smoothness, rhythmicity) fail to do so. Interventions targeting these ought to be leveraged for performance enhancement in PD through neuroprotective and brain network connectivity strengthening. It remains to be ascertained to which extent these are amenable to modulation.Entities:
Keywords: Biomechanical assessment; Gait; Kinematic analysis; Parkinson's disease; Physical activity
Mesh:
Year: 2022 PMID: 35426538 PMCID: PMC9011371 DOI: 10.1007/s00702-022-02501-9
Source DB: PubMed Journal: J Neural Transm (Vienna) ISSN: 0300-9564 Impact factor: 3.850
Clinical and demographic data of the study participants
| Mean | SD | SEM | Median | |
|---|---|---|---|---|
| Age (y) | 68.77 | 12.08 | 1.934 | 47 |
| UPDRS III | 38.21 | 12.1 | 1.937 | 52 |
| PASE | 89.41 | 72.22 | 11.56 | 286.8 |
| Educational attainment (y) | 8,.706 | 4.869 | 0.8343 | 16 |
| Age at onset (y) | 61.33 | 12.31 | 1.971 | 49 |
| Disease duration (y) | 7.436 | 3.339 | 0.5346 | 13 |
| LEDD | 695.1 | 442.8 | 70.91 | 1973 |
| BMI | 26.05 | 5.109 | 0.8636 | 21.60 |
| PDQ-8 | 26.24 | 18.04 | 3.141 | 63 |
Fig. 1Scatter plots for selected raw clinical and demographic values with Spearman’s coefficients and respective p values (A). Sub-plot (B) represents the MDS-UPDRS part III breakdown into its motor subs-cores and respective correlation with the Physical Activity Scale for the Elderly (PASE) scores. Shaded areas correspond to a local polynomial regression fitting (loess). For the entire correlation matrixes, please refer back to Supplementary Fig. S8
Fig. 2Mediation analysis results revealing how the impact of physical activity on quality-of-life “goes through” its effect over motor function as assessed by the MDS-UPDRS part III scale
Fig. 3Effect size plot for the correlation between physical activity as assessed by the Physical Activity Scale for the Elderly (PASE) scores and each principal component (P1 to P10) score (A). Statistical significance is indicated as < 0.05 *, < 0.01 ** or < 0.001 ***
Fig. 4Factor loadings of each kinematic variable after varimax rotation. Only values ≥ 0.4 are shown. RC rotated component